216 related articles for article (PubMed ID: 20420498)
1. Genetics of medulloblastoma: clues for novel therapies.
Onvani S; Etame AB; Smith CA; Rutka JT
Expert Rev Neurother; 2010 May; 10(5):811-23. PubMed ID: 20420498
[TBL] [Abstract][Full Text] [Related]
2. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
4. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.
Pollack IF
J Neurosurg Pediatr; 2011 Aug; 8(2):135-48. PubMed ID: 21806354
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma.
Dhall G
J Child Neurol; 2009 Nov; 24(11):1418-30. PubMed ID: 19841429
[TBL] [Abstract][Full Text] [Related]
6. The molecular genetics of medulloblastoma: an assessment of new therapeutic targets.
Carlotti CG; Smith C; Rutka JT
Neurosurg Rev; 2008 Oct; 31(4):359-68; discussion 368-9. PubMed ID: 18548301
[TBL] [Abstract][Full Text] [Related]
7. Molecular changes in brain tumors: prognostic and therapeutic impact.
Sanson M; Laigle-Donadey F; Benouaich-Amiel A
Curr Opin Oncol; 2006 Nov; 18(6):623-30. PubMed ID: 16988585
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments?
Brandes AA; Paris MK; Basso U
Expert Rev Anticancer Ther; 2003 Oct; 3(5):615-20. PubMed ID: 14599085
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma development: tumor biology informs treatment decisions.
Gopalakrishnan V; Tao RH; Dobson T; Brugmann W; Khatua S
CNS Oncol; 2015; 4(2):79-89. PubMed ID: 25768332
[TBL] [Abstract][Full Text] [Related]
10. [Medulloblastoma: towards new prognostic factors].
San-Galli F; Maire JP; Guérin J
Neurochirurgie; 1991; 37(1):3-11. PubMed ID: 2017290
[TBL] [Abstract][Full Text] [Related]
11. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Remke M; Hielscher T; Korshunov A; Northcott PA; Bender S; Kool M; Westermann F; Benner A; Cin H; Ryzhova M; Sturm D; Witt H; Haag D; Toedt G; Wittmann A; Schöttler A; von Bueren AO; von Deimling A; Rutkowski S; Scheurlen W; Kulozik AE; Taylor MD; Lichter P; Pfister SM
J Clin Oncol; 2011 Oct; 29(29):3852-61. PubMed ID: 21911727
[TBL] [Abstract][Full Text] [Related]
12. Molecular array analyses of 51 pediatric tumors shows overlap between malignant intracranial ectomesenchymoma and MPNST but not medulloblastoma or atypical teratoid rhabdoid tumor.
Kleinschmidt-DeMasters BK; Lovell MA; Donson AM; Wilkinson CC; Madden JR; Addo-Yobo SO; Lillehei KO; Foreman NK
Acta Neuropathol; 2007 Jun; 113(6):695-703. PubMed ID: 17431644
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
14. [Childhood medulloblastoma].
Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
[TBL] [Abstract][Full Text] [Related]
15. Recent developments and current concepts in medulloblastoma.
Gerber NU; Mynarek M; von Hoff K; Friedrich C; Resch A; Rutkowski S
Cancer Treat Rev; 2014 Apr; 40(3):356-65. PubMed ID: 24389035
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and molecular biological characterization of an adult medulloblastoma.
Holland H; Koschny R; Krupp W; Meixensberger J; Bauer M; Schober R; Kirsten H; Ganten TM; Ahnert P
Cancer Genet Cytogenet; 2007 Oct; 178(2):104-13. PubMed ID: 17954265
[TBL] [Abstract][Full Text] [Related]
17. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway.
Gokhale A; Kunder R; Goel A; Sarin R; Moiyadi A; Shenoy A; Mamidipally C; Noronha S; Kannan S; Shirsat NV
J Cancer Res Ther; 2010; 6(4):521-9. PubMed ID: 21358093
[TBL] [Abstract][Full Text] [Related]
18. Advances in the treatment of pediatric brain tumors.
Rutka JT; Kuo JS; Carter M; Ray A; Ueda S; Mainprize TG
Expert Rev Neurother; 2004 Sep; 4(5):879-93. PubMed ID: 15853514
[TBL] [Abstract][Full Text] [Related]
19. Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights.
Khatua S; Song A; Citla Sridhar D; Mack SC
Curr Neuropharmacol; 2018; 16(7):1045-1058. PubMed ID: 29189165
[TBL] [Abstract][Full Text] [Related]
20. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.
de Haas T; Hasselt N; Troost D; Caron H; Popovic M; Zadravec-Zaletel L; Grajkowska W; Perek M; Osterheld MC; Ellison D; Baas F; Versteeg R; Kool M
Clin Cancer Res; 2008 Jul; 14(13):4154-60. PubMed ID: 18593994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
